OUR TEAM & LEGACY
We’ve been around the block a few times. In fact, our legacy spans decades and our neighborhood spans the world.
At HVH, trust is at the core of everything we do. We are fully engaged in doing the right thing every time—in our tasks, in our interactions with co-workers, in serving our clients, and in being true to ourselves. By building trust and fostering solid teamwork, we celebrate our individual achievements, as well as our collective success as a company. We consistently strive for—and achieve—success.
Ours is a culture of learning, growth, and evolution. We embrace impermanence and welcome change so that we can continuously find new ways to help our clients benefit from the ongoing advances in AI and other cutting edge technologies. Our highly skilled team is comprised of scientists, data analysts and architects, designers, engineers, physicians, business experts, and more. But we are also dreamers, builders, investigators, visionaries, inventors, and creatives. We are constantly innovating.
Our Partner Companies
Havas is one of the world’s largest global communications groups. Founded in 1835 in Paris, the Group employs 20,000 people in over 100 countries and is fully integrated into Vivendi. Havas Group is committed to being the world’s best company at creating meaningful connections between people and brands through creativity, media and innovation. Based on a client-centric model across media and creative, the Havas Group is the most integrated company in its sector.
Perspecta brings a diverse set of capabilities to U.S. government customers in defense, intelligence, civilian, healthcare, and state and local markets. Perspecta has 260+ issued, licensed and pending patents. With offerings in mission services, digital transformation and enterprise operations, Perspecta’s team of 14,000 engineers, analysts, investigators and architects works tirelessly to not only execute the mission, but build and support the backbone that enables it. Perspecta was formed to take on big challenges, is an engine for growth and success, and enables its customers to build a better nation.
Steve Costalas has been the chief executive officer of HVH since our inception. Prior to taking on this role, he led Vencore Health Analytics and served as senior vice president and general counsel of Vencore—a 4,000-person organization that provides information solutions, engineering, and analysis to the U.S. Intelligence Community, Department of Defense, and Civilian Agencies-and is now part of Perspecta. During his time at Vencore, Steve headed up legal and ethics, corporate development, contracts, pricing, procurement, and property management organizations. Prior to joining Vencore, Steve was counsel at Dechert LLP, an international law firm, where he led teams structuring corporate acquisitions and dispositions, equity investments, and complex collaborations, with focus in the life sciences industry. At one time, Steve served as general counsel and head of corporate development of Pharmacopeia, a public biopharmaceutical company. Steve graduated with honors from Dartmouth College and from the Law School of the University of Pennsylvania. He is a member of the Board of Directors and chair of the Audit Committee of the Iraq and Afghanistan Veterans of America—a leading post-9/11 veteran’s nonprofit organization.
Oodaye Shukla is the chief data and analytics officer of HVH. His broad experience in such industries as health care, telecom, the U.S. Department of Defense, and U.S. intelligence Community, spans more than 20 years. Oodaye started his career at the Johns Hopkins Applied Physics Lab, building optical and digital computers and developing neural network models to objectively assess cataract severity. In previous positions at Lucent Technology and Siemens Telecom, Oodaye worked on semiconductor lasers and receivers, 1.6 TB/s optical long-haul systems, and was responsible for a $20 million product portfolio. He joined Lockheed Martin (which later became Vencore) in 2004, to manage the development of a large-scale satellite communications simulation model. Oodaye spearheaded the first efforts in finding undiagnosed rare disease patients, which led to the formation of HVH Precision Analytics. He earned a bachelor’s degree in electrical engineering from The Pennsylvania State University; a master’s degree in electrical engineering (optical signal processing) from The John Hopkins University; a master’s degree in electrical engineering (neural networks) from the University of Maryland; and master’s degree in Technology Management from the University of Pennsylvania/The Wharton School.
Pierantonio Russo, MD, FCPP, FAAP, is the Chief Medical Officer for HVH. An experienced cardiac surgeon, Pierantonio also has served as a health care executive at national payer organizations. From 1988 to 2007, he held academic, clinical, and administrative leadership positions including his role as chief of cardiac surgery and heart transplantation; director of the Heart Institute; and director of the cardiac intensive care unit at St. Christopher’s Hospital for Children. Pierantonio also served as chief of cardiac surgery and surgical director of the cardiac intensive care unit at the University of Missouri Hospital. In addition, Pierantonio spent more than 10 years in senior medical positions at Independence Blue Cross and Harvard Pilgrim payer systems and as Chief Medical Officer at a BCBSA backed Population Health Organization. Previous academic positions include those in surgery and pediatrics at University of Missouri, as well as at Philadelphia-based Temple Medical School, Thomas Jefferson Medical College, and Allegheny University of the Health Sciences. Pierantonio also held academic positions in postgraduate master’s of business administration programs at the Wharton School of Business (international Program) and at Harvard Medical School, where he lectured on the topic of population medicine. Active within a variety of professional organizations, Pierantonio is a fellow of the College of Physicians of Philadelphia, fellow of the American Academy of Pediatrics, and serves as a member of the Society of Thoracic Surgeons. In addition to being the first author/co-author of 55 peer-reviewed publications, Pierantonio has authored meeting abstracts and presented at professional medical societies worldwide. He also sits on the advisory board of various health care organizations. Pierantonio attended Bologna Medical School and continued his training in cardiovascular surgery at Great Ormond Street Hospital and the Mayo Clinic, Rochester, Minn.
Jennifer Furniss is VP, Finance & Operations for HVH Precision Analytics. Prior to joining the company, Jennifer served as director of financial planning & analysis for Perspecta. She has diverse business experience, with a focus on financial analysis and reporting, cash management, long- range planning, risk and opportunity management, acquisition integrations, system implementations, and business process improvement. Jennifer started her career at Lockheed Martin in the Financial Leadership Development program. During her 14-year career, she held roles of increasing responsibility in finance and business operations and completed the Executive Development Growth Enhancement Program. Jennifer holds a Bachelor of Business Administration in Finance Degree, and a Master’s Degree in Business Administration from Kent State University, as well as a Master of Arts in International Business Degree from Groupe École Supérieure de Commerce de Rennes, France. Jennifer is Lean Six Sigma certified and serves on the board of Comfort Caring Canines Therapy Dog, Inc.
Dr. Mack is Chief Commercial Officer at HVH Precision Analytics. He and his team work with life science industry partners to develop and implement innovative solutions that leverage HVH’s real world data and platform. He joined HVH from Veradigm Health. At Veradigm health he was Area Vice President, Life Science Sales working with life science partners to develop and implement HEOR and RWE projects. Prior to Veradigm Health, Dr. Mack was Director of National Accounts at Practice Fusion. He helped develop the Clinical Data Solutions team was charged with developing National Data Partnerships. Over the span of his career, Steve has worked with multiple integrated patient level datasets developing analytic solutions geared towards both commercial brands and HEOR/RWE teams. He has held previous positions at GE Healthcare, IMS, and SDI Health. He holds a B.S. in Pharmacy and a Doctor of Clinical Pharmacy from Duquesne University.
Want to learn how SCIPHER—our proprietary groundbreaking AI/machine learning platform—can help you ask better questions?